fluperolone acetate

{{Short description|Chemical compound}}

{{Drugbox

| verifiedrevid = 447611718

| IUPAC_name = (2S)-1-[(1R,2S,10S,11S,14R,15S,17S)-1-fluoro-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-14-yl]-1-oxopropan-2-yl acetate

| image = Fluperolone acetate.svg

| width = 250

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|correct|??}}

| CAS_number = 2119-75-7

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = DOL7Q9DPF9

| ATC_prefix = D07

| ATC_suffix = AB05

| PubChem = 66257

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| ChemSpiderID = 59639

| KEGG = D04225

| C=24 | H=31 | F=1 | O=6

| synonyms = 9α-Fluoro-11β,17α,21-trihydroxy-21-methylpregna-1,4-diene-3,20-dione 21-acetate

| smiles = C[C@@H](C(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)O)OC(=O)C

| StdInChI = 1S/C24H31FO6/c1-13(31-14(2)26)20(29)23(30)10-8-17-18-6-5-15-11-16(27)7-9-21(15,3)24(18,25)19(28)12-22(17,23)4/h7,9,11,13,17-19,28,30H,5-6,8,10,12H2,1-4H3/t13-,17-,18-,19-,21-,22-,23-,24-/m0/s1

| StdInChIKey = HHPZZKDXAFJLOH-QZIXMDIESA-N

}}

Fluperolone acetate is a corticosteroid. It has been used topically.{{cite journal | vauthors = Thorne N | title = A clinical trial of Fluperolone, a new topical steroid | journal = Postgraduate Medical Journal | volume = 39 | issue = 449| pages = 159–60 | date = March 1963 | pmid = 13984971 | pmc = 2482046 | doi = 10.1136/pgmj.39.449.159 }}

References

{{Reflist}}

{{Glucocorticoids}}

{{Glucocorticoidics}}

Category:Corticosteroid esters

Category:Corticosteroids

Category:Organofluorides

Category:Acetate esters

{{dermatologic-drug-stub}}